The virtual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2021 brought together leading experts in GI cancer who updated the community on the latest data and hot topics in the field.

In this podcast, Tobias Arkenau, MD, PhD, Sarah Cannon Research Institute UK, London, UK, chairs an insightful panel discussion on the some of exciting developments presented at ASCO GI 2021 in colorectal, gastric and bile duct cancer. He was joined by Lizzy Smyth, MD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, Nataliya Uboha, MD, PhD, University of Wisconsin, Madison, WI and Kai-Keen Shiu, FRCP, PhD, University College London Hospitals NHS Foundation Trust, London, UK.

Hear the expert panel offer their perspectives on pembrolizumab in colorectal cancer & KEYNOTE-177, the latest studies evaluating therapies targeting FGFR2 and HER2 in both gastric cancer and cholangiocarcinoma, CAR-T advances in GI cancer and how the gut microbiome could be used to predict response to immune-checkpoint blockade.